OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology
Carlo G. Tocchetti, Dimitrios Farmakis, Yvonne Koop, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2055-2076
Closed Access | Times Cited: 13

Showing 13 citing articles:

Recent Developments in the Management of Renal Cell Cancer
Yu‐Wei Chen, Justine Panian, Brent S. Rose, et al.
JCO Oncology Practice (2025)
Closed Access | Times Cited: 1

CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury
Jiawan Wang, Heng Du, Wanrun Xie, et al.
Circulation Research (2024) Vol. 135, Iss. 12, pp. 1161-1174
Closed Access | Times Cited: 6

Mechanisms and Management of Arrhythmias in Cancer Patients
Manyoo Agarwal, Aadhavi Sridharan, Hoang Nhat Pham, et al.
Current Treatment Options in Cardiovascular Medicine (2025) Vol. 27, Iss. 1
Closed Access

Beyond Myocarditis: Exploring the Vascular Impact of Immune Checkpoint Inhibitors
Brett W. Sperry, Patrick J. Miller
Circulation Cardiovascular Imaging (2025)
Closed Access

A review on polysaccharide-based tumor targeted drug nanodelivery systems
Liangxing Tu, Banghuai Xing, Shenglin Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 140820-140820
Closed Access

Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case
Samia Boussouar, Etienne Charpentier, Baptiste Abbar, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access

Baicalin reduced vandetanib induced myocardial injury by regulating redox balance and NLRP3 inflammasome pathway
Fen Wang, Jianwei Li, Zhixuan Zhang, et al.
Tissue and Cell (2025) Vol. 94, pp. 102795-102795
Closed Access

Immune checkpoint inhibitors: Unraveling atherosclerotic cardiovascular risk.
Rhys Gray, Charlotte Manisty, Richard K. Cheng, et al.
Atherosclerosis (2025) Vol. 403, pp. 119147-119147
Closed Access

An update on the European Society of Cardiology Council of Cardio-Oncology
Teresa López‐Fernández, Peter van der Meer, Alexander R. Lyon
European Heart Journal (2025)
Closed Access

Ganoderma atrum polysaccharide inhibits ROS/NLRP3/pyroptosis axis by fixing mitochondrial dynamics disorder in PD-1 inhibitors-induced carditis of Lewis lung carcinoma mice
Xiaoyu Mu, Sheng-bin Chen, Song-yu Yang, et al.
International Journal of Biological Macromolecules (2025), pp. 143163-143163
Closed Access

Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association
Sadiya S. Khan, Khadijah Breathett, Lynne T. Braun, et al.
Circulation (2025)
Closed Access

The Good (Tumor Killing) and the Bad (Cardiovascular Complications) of Immunologic Checkpoint Inhibitors
María T. Gamero, Amar Patel, Eugene Storozynsky
Current Cardiology Reports (2024)
Open Access | Times Cited: 1

Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation
Varius Dannenberg, Flora Zschocke, Kseniya Halavina, et al.
European Journal of Clinical Investigation (2024)
Closed Access

Page 1

Scroll to top